Warning: include(/home/quintpub/public_html/journals/prd/includes/code.php) [function.include]: failed to open stream: No such file or directory in /home/quintpub/public_html/journals/prd/abstract.php on line 2

Warning: include() [function.include]: Failed opening '/home/quintpub/public_html/journals/prd/includes/code.php' for inclusion (include_path='.:/usr/lib/php:/usr/local/lib/php') in /home/quintpub/public_html/journals/prd/abstract.php on line 2
Use of Biodegradable Polylactic Acid Barrier Materials in the Treatment of Grade II Periodontal Furcation Defects in Humans--Part I: A Multicenter Investigative Clinical Study
Warning: include(/home/quintpub/public_html/journals/prdincludes/05_update/javascript.php) [function.include]: failed to open stream: No such file or directory in /home/quintpub/public_html/journals/prd/abstract.php on line 39

Warning: include() [function.include]: Failed opening '/home/quintpub/public_html/journals/prdincludes/05_update/javascript.php' for inclusion (include_path='.:/usr/lib/php:/usr/local/lib/php') in /home/quintpub/public_html/journals/prd/abstract.php on line 39
Follow Us      

LOGIN

   Official Journal of The Academy of Osseointegration

 
Share Page:
Back

Volume 18 , Issue 6
November/December 1998

Pages 573-585


Use of Biodegradable Polylactic Acid Barrier Materials in the Treatment of Grade II Periodontal Furcation Defects in Humans--Part I: A Multicenter Investigative Clinical Study

Vernino/Ringeisen/Wang/Derhalli/Rapley/Nechamkin/Brekke


PMID: 10321172
DOI: 10.11607/prd.00.0295

This study evaluated two bioresorbable polylactic acid barriers (Epi-Guide and Guidor) to determine if design differences were of therapeutic significance in the treatment of Grade II furcation defects in humans. Forty patients with bilaterally matched, Grade II furcation defects in maxillary or mandibular first or second molars were treated in a multicenter study. Comprehensive initial periodontal therapy, follwed by defect debridement and root preparation, preceded randomized membrane placement. Data collected from all three investigative centers were pooled and analyzed using an analysis of variance appropriate for a counterbalancing design. Both barrier types produced measurable improvements of clinical probing values. Barrier exposure scores taken through the eighth week postoperative revealed that Epi-Guide was less likely to become exposed than Guidor. The findings of this study, which was conducted over a 12-month period, demonstrated that Epi-Guide and Guidor were comparable as measured by clinical probing determinations.


Full Text PDF File | Order Article

 

 
Get Adobe Reader
Adobe Acrobat Reader is required to view PDF files. This is a free program available from the Adobe web site.
Follow the download directions on the Adobe web site to get your copy of Adobe Acrobat Reader.

 

© 2020 Quintessence Publishing Co, Inc

PRD Home
Current Issue
Ahead of Print
Archive
Author Guidelines
About
Submission Form
Submit
Reprints
Permission
Advertising
Quintessence Home
Terms of Use
Privacy Policy
About Us
Contact Us
Help